Target Name: CLEC4C
NCBI ID: G170482
Review Report on CLEC4C Target / Biomarker Content of Review Report on CLEC4C Target / Biomarker
CLEC4C
Other Name(s): C-type lectin domain family 4 member C, transcript variant 1 | dendritic lectin | MGC125792 | C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily member 11 | CLEC4C variant 1 | Blood dendritic cell antigen 2 protein | dendritic cell lectin b | Dendritic cell lectin b | BDCA-2 | CD303 | MGC125789 | CLC4C_HUMAN | C-type lectin superfamily member 7 | C-type lectin domain family 4, member C, isoform 1 | PRO34150 | BDCA2 | C-type lectin domain family 4 member C | blood dendritic cell antigen 2 protein | MGC125793 | HECL | DLEC | C-type lectin domain family 4 member C (isoform 1) | MGC125791 | Blood dendritic cell antigen 2 | CLECSF7 | Dendritic lectin | C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily member 7 | CLECSF11 | C-type lectin domain family 4, member C

CLEC4C: A Drug Target / Disease Biomarker

CLEC4C, also known as G protein-coupled receptor 4C, is a protein that is expressed in various tissues throughout the body. It is a member of the G protein-coupled receptor family, which is a large family of transmembrane proteins that play an important role in cellular signaling. G protein-coupled receptors are involved in a wide range of physiological processes, including sensory perception, neurotransmitter signaling, and hormone regulation.

One of the key functions of G protein-coupled receptors is to transmit signals from the cell surface to the intracellular signaling pathway. When a G protein-coupled receptor is activated, it sends a signal to the intracellular signaling pathway, which then triggers a series of downstream signaling pathways that ultimately result in the production of a specific protein or the modification of a particular protein.

CLEC4C is a protein that is expressed in various tissues throughout the body, including the brain, heart, and peripheral tissues. It is involved in a wide range of physiological processes, including neurotransmitter signaling, pain perception, and hormone regulation.

One of the key functions of CLEC4C is its role in neurotransmitter signaling. CLEC4C is involved in the regulation of neurotransmitter release from neurons, which is critical for the transmission of signals in the nervous system. clec4c-/- mice have reduced neurotransmitter release and increased sensitivity to neurotransmitter agonists, suggesting a role for clec4c in neurotransmitter signaling.

CLEC4C is also involved in pain perception. clec4c-/- mice have reduced pain sensitivity and an increased ability to escape from painful stimuli, suggesting a role for clec4c in modulating pain sensitivity.

CLEC4C is also involved in hormone regulation. clec4c-/- mice have reduced insulin sensitivity and increased sensitivity to androgens, suggesting a role for clec4c in modulating hormone regulation.

CLEC4C is a protein that is involved in a wide range of physiological processes. Its function in neurotransmitter signaling, pain perception, and hormone regulation makes it an attractive drug target. Further research is needed to fully understand the role of clec4c in these processes and to develop effective therapies based on clec4c.

Protein Name: C-type Lectin Domain Family 4 Member C

Functions: Lectin-type cell surface receptor which may play a role in antigen capturing by dendritic cells (PubMed:11748283, PubMed:21880719, PubMed:25995448). Specifically recognizes non-sialylated galactose-terminated biantennary glycans containing the trisaccharide epitope Gal(beta1-3/4)GlcNAc(beta1-2)Man (PubMed:21880719, PubMed:25995448). Binds to serum IgG (PubMed:25995448). Efficiently targets ligand into antigen-processing and peptide-loading compartments for presentation to T-cells (PubMed:11748283). May mediate potent inhibition of induction of IFN-alpha/beta expression in plasmacytoid dendritic cells (PubMed:11748283, PubMed:21880719). May act as a signaling receptor that activates protein-tyrosine kinases and mobilizes intracellular calcium (PubMed:11748283)

The "CLEC4C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CLEC4C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CLEC4D | CLEC4E | CLEC4F | CLEC4G | CLEC4GP1 | CLEC4M | CLEC4OP | CLEC5A | CLEC6A | CLEC7A | CLEC9A | CLECL1P | CLGN | CLHC1 | CLIC1 | CLIC1P1 | CLIC2 | CLIC3 | CLIC4 | CLIC5 | CLIC6 | CLINT1 | CLIP1 | CLIP1-AS1 | CLIP2 | CLIP3 | CLIP4 | CLK1 | CLK2 | CLK2P1 | CLK3 | CLK4 | CLLU1 | CLLU1-AS1 | CLMAT3 | CLMN | CLMP | CLN3 | CLN5 | CLN6 | CLN8 | CLNK | CLNS1A | CLOCK | CLP1 | CLPB | CLPP | CLPS | CLPSL1 | CLPSL2 | CLPTM1 | CLPTM1L | CLPX | CLRN1 | CLRN1-AS1 | CLRN2 | CLRN3 | CLSPN | CLSTN1 | CLSTN2 | CLSTN3 | CLTA | CLTB | CLTC | CLTCL1 | CLTH complex | CLTRN | CLU | CLUAP1 | CLUH | CLUHP3 | CLUHP8 | CLUL1 | CLVS1 | CLVS2 | CLXN | CLYBL | CLYBL-AS1 | CLYBL-AS2 | CLYBL-AS3 | CMA1 | CMAHP | CMAS | CMBL | CMC1 | CMC2 | CMC4 | CMG Helicase Complex | CMIP | CMKLR1 | CMKLR2 | CMKLR2-AS | CMPK1 | CMPK2 | CMSS1 | CMTM1 | CMTM2 | CMTM3 | CMTM4 | CMTM5